GPT and steatosis: In hypercholesterolemic Wistar rats fed with high cholesterol and fat diet, 1 mL/Kg b.w. or 30 mg/Kg b.w. BCP administration correlated with decreased hepatomegaly, lower hepatic lipid accumulation and steatosis, and decreased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities; the hypolipidemic effects were mediated through inhibition of the hepatic HMG-CoA reductase [126,135].